JPRN-UMIN000002749已完成未知
Quantification of Epstein-Barr virus DNA in patients undergoing SMILE chemotherapy for relapsed/refractory mature T-cell lymphoma - Quantification of Epstein-Barr virus DNA in patients undergoing SMILE chemotherapy for relapsed/refractory mature T-cell lymphoma
K-cell Tumor Study Group0 个研究点目标入组 42 人开始时间: 2009年11月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 69years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Quantitative Analysis of Cell-free Epstein-Barr Virus and Human papilloma virus DNA as a Biomarker in patients with Nasopharyngeal and Oropharyngeal carcinomas: Prospective single-center studyNeoplasmsKCT0006647ational Cancer Center60
已完成
不适用
Quantification of Epstein-Barr virus DNA in patients undergoing SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphomauntreated stage IV or relapsed/refractory NK/T-cell lymphomaJPRN-UMIN000000741K-cell Tumor Study Group28
已完成
不适用
A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient PopulationsMouth CancerThroat CancerLip NeoplasmsHead and Neck CancersLip CancerNCT00186433Stanford University49
已完成
不适用
Detection of EBV miRNA in human bloodDRKS00010713niversitätsklinikum Jena149
招募中
不适用
A study for of the infection status of Epstein-Barr virus in healthy young adultshealthy young adultsJPRN-UMIN000032099Japan Agency for Medical Research and development400